PARLIAMENTARY WRITTEN QUESTION
NHS: Drugs (12 February 2019)

To ask the Secretary of State for Health and Social Care, how patient organisations will be involved in the scoping for a review of NICE technology appraisal methods included in the 2019 voluntary scheme for branded medicines pricing and access.

Asked by:
Darren Jones (Labour)

The National Institute for Health and Care Excellence (NICE) is in the process of planning how to conduct its scoping of the review of the methods for technology appraisal and highly specialised technologies evaluations. Scoping will involve patient organisations and other relevant stakeholders, including industry. The project of scoping and review of the technology appraisal and highly specialised technologies methods and processes is timetabled in the 2019/20 business year. Additional detail and more information will be made available on the NICE website in due course.

Answered by:
Steve Brine (Conservative)
18 February 2019